|
|
PHOTO ESSAY |
|
Year : 2018 | Volume
: 66
| Issue : 7 | Page : 993-994 |
|
Clinical presentation following photorefractive intrastromal cross-linking for myopic correction
Gitansha Shreyas Sachdev, Shreyas Ramamurthy
Refractive Services, The Eye Foundation, Coimbatore, Tamil Nadu, India
Date of Submission | 07-Jan-2018 |
Date of Acceptance | 14-Mar-2018 |
Date of Web Publication | 25-Jun-2018 |
Correspondence Address: Gitansha Shreyas Sachdev The Eye Foundation, 582-A, DB Road, RS Puram, Coimbatore - 641 002, Tamil Nadu India
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/ijo.IJO_1227_17
Keywords: Collagen cross-linking, myopia, photorefractive intrastromal cross-linking
How to cite this article: Sachdev GS, Ramamurthy S. Clinical presentation following photorefractive intrastromal cross-linking for myopic correction. Indian J Ophthalmol 2018;66:993-4 |
Case Report | | |
A 23-year old female presented to our Refractive Services seeking independence from spectacles. Her unaided distance visual acuity (UDVA) was 6/18 and 6/6 in the right and left eye, respectively. The best-corrected distance visual acuity in the right eye was 6/6 with a stable refractive correction of − 1.25 Diopter (D) sphere for the past 3 years. Anterior segment and fundus evaluation were within normal limits. Corneal topography was within normal limits with a mean keratometry (Km) of 46.2D and a thinnest pachymetry of 530 um [Figure 1]. Photorefractive intrastromal cross-linking (PiXL) for the right eye was performed. A written informed consent was obtained before the procedure. High fluence ultraviolet-A irradiation of 15 J/cm 2 was delivered over the central 4 mm, using the Mosaic device (Avedro, Waltham, MA). Oxygen was supplemented externally to increase the efficacy of the transepithelial approach. At 1-month postoperative visit, her UDVA in the right eye was 6/6. Slit lamp evaluation revealed a central 4 mm disc of haze with a corresponding demarcation line on anterior segment optical coherence tomography [Figure 2] and [Figure 3]. Corneal topography at 3 months demonstrates a flattening in the central 4 mm zone with a Km of 44.4D [Figure 4]. No regression or endothelial cell loss was noted over the 6-month follow-up period. On administrating the questionnaire, the patient reported freedom from glasses for 100% of her activities with a satisfaction score of 5/5. | Figure 1: Preoperative corneal tomography with a mean keratometry of 46.2D
Click here to view |
| Figure 2: Slit lamp evaluation at 1-month postoperative visit reveals a central disc of haze
Click here to view |
| Figure 3: Anterior segment optical coherence tomography demonstrating a well-defined demarcation line in the central 4 mm zone
Click here to view |
| Figure 4: Corneal tomography at 3 months demonstrates a central corneal flattening of 1.8D
Click here to view |
Discussion | | |
Kanellopoulos described the preliminary results of PiXL and noted an average corneal flattening of 1.4 D at 1 month.[1] Lim et al. demonstrated the results in a cohort of 14 eyes with a mean reduction in spherical equivalent of 0.72 ± 0.43D using the epithelium on approach.[2] Elling et al. demonstrated superior visual outcomes in 26 eyes undergoing PiXL following epithelial debridement.[3]
Conclusion | | |
This photo essay demonstrates the clinical changes which ensue following PiXL, which were not demonstrated in the published data.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References | | |
1. | Kanellopoulos AJ. Novel myopic refractive correction with transepithelial very high-fluence collagen cross-linking applied in a customized pattern: Early clinical results of a feasibility study. Clin Ophthalmol 2014;8:697-702. [ PUBMED] |
2. | Lim WK, Soh ZD, Choi HK, Theng JT. Epithelium-on photorefractive intrastromal cross-linking (PiXL) for reduction of low myopia. Clin Ophthalmol 2017;11:1205-11. |
3. | Elling M, Kersten-Gomez I, Dick HB. Photorefractive intrastromal corneal crosslinking for the treatment of myopic refractive errors: Six-month interim findings. J Cataract Refract Surg 2017;43:789-95. [ PUBMED] |
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
This article has been cited by | 1 |
Two-photon collagen crosslinking in ex vivo human corneal lenticules induced by near-infrared femtosecond laser |
|
| Zhenzhou Cheng, Nan Zhang, Le Chang, Pengfei Qi, Lin Zhang, Lie Lin, Yan Wang, Weiwei Liu | | Journal of Biophotonics. 2022; | | [Pubmed] | [DOI] | | 2 |
Corneal Crosslinking in Refractive Corrections |
|
| Viral V. Juthani, Roy S. Chuck | | Translational Vision Science & Technology. 2021; 10(5): 4 | | [Pubmed] | [DOI] | | 3 |
Visual and Topographic Improvement with Epithelium-On, Oxygen-Supplemented, Customized Corneal Cross-Linking for Progressive Keratoconus |
|
| Kazutaka Kamiya, Shunsuke Kanayama, Masahide Takahashi, Nobuyuki Shoji | | Journal of Clinical Medicine. 2020; 9(10): 3222 | | [Pubmed] | [DOI] | |
|
|
|
|